Met Life Investment Management, LLC Rezolute, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 42,229 shares of RZLT stock, worth $374,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,229Holding current value
$374,148% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RZLT
# of Institutions
98Shares Held
59.5MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$124 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$35.6 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$31.5 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$26.9 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$26.9 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $344M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...